After years of focused and intensive work on the FYB201 project, we have reached a significant milestone for Formycon – our first FDA approval. This is not only a reason to celebrate but also to highlight the special contribution of the entire #TeamFormycon. Each and every one of us can be extremely proud of what we have achieved. It’s been an incredible journey – and we’re up for more! But for now: cheers and thanks to all of you!
August 4, 2022
We will keep you up to date!News Distributor Subscription
Global Quality Biosimilars
© Formycon AGLegal Notice Data Protection